Heranba Industries Ltd

Heranba Industries Ltd

₹ 286 -1.70%
28 Mar 2:43 p.m.
About

Incorporated in 1994, Heranba Industries Ltd is engaged in the manufacturing of a diverse range of agrochemicals such as insecticides, herbicides, fungicides and public health products for pest control. [1]

Key Points

Product Portfolio
The Co.’s portfolio comprises intermediates, technicals and formulations.
Intermediates: Intermediates manufactured are for Co.’s own captive consumption for manufacturing various Technicals and Formulations. [1] These include CMAC, Bromobenzenes, Metaphenoxy, etc.
Technicals: These include Cypermethrin, Deltamethrin, Alpha Cypermethrin, Acephate, Lambda Cyhalothrin, etc.
Formulations: Formulations and branding of formulations are a forward integration to Heranba’s technical business. These include Emulsifiable Concentrate (EC), Water Dispersible Granule (WDG), Suspension concentrate, Capsule Suspension (CS), etc.
It has 400 product registrations in 49 countries,210 registrations in pipeline in 49 countries. 24 Technicals,193 formulations are registered for manufacture & sale in India.68 technicals & 65 formulations are registered for manufacture and sale in export markets
{#https://www.bseindia.com/bseplus/AnnualReport/543266/73414543266_05_07_22.pdf#page=4 #}

  • Market Cap 1,146 Cr.
  • Current Price 286
  • High / Low 426 / 268
  • Stock P/E 17.0
  • Book Value 211
  • Dividend Yield 0.43 %
  • ROCE 17.7 %
  • ROE 14.3 %
  • Face Value 10.0

Pros

  • Company has a good return on equity (ROE) track record: 3 Years ROE 25.0%

Cons

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Loading peers table ...

Quarterly Results

Standalone Figures in Rs. Crores / View Consolidated

Dec 2020 Mar 2021 Jun 2021 Sep 2021 Dec 2021 Mar 2022 Jun 2022 Sep 2022 Dec 2022 Mar 2023 Jun 2023 Sep 2023 Dec 2023
332 268 351 353 395 350 362 423 280 259 282 430 302
268 210 287 292 324 288 316 357 255 236 280 383 273
Operating Profit 64 58 65 61 71 63 46 66 26 23 2 47 28
OPM % 19% 22% 18% 17% 18% 18% 13% 16% 9% 9% 1% 11% 9%
1 5 4 5 5 5 4 4 1 4 8 5 7
Interest 1 1 1 1 1 1 1 2 2 3 2 2 3
Depreciation 4 4 4 4 4 8 5 6 6 6 6 6 6
Profit before tax 60 58 64 61 71 58 44 63 18 18 2 44 26
Tax % 26% 25% 26% 26% 25% 27% 24% 25% 22% 21% 26% 26% 26%
45 43 47 46 53 43 34 48 14 14 2 33 19
EPS in Rs 11.45 10.80 11.84 11.40 13.37 10.64 8.42 11.92 3.60 3.58 0.38 8.12 4.80
Raw PDF

Profit & Loss

Standalone Figures in Rs. Crores / View Consolidated

Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 TTM
514 582 741 1,004 951 1,219 1,450 1,324 1,272
470 534 653 873 822 997 1,190 1,163 1,173
Operating Profit 44 48 88 131 129 221 260 161 100
OPM % 9% 8% 12% 13% 14% 18% 18% 12% 8%
1 2 5 7 17 7 19 14 24
Interest 13 12 12 11 9 5 4 8 10
Depreciation 4 4 5 6 8 15 20 23 24
Profit before tax 28 35 76 122 129 208 255 144 90
Tax % 39% 41% 39% 38% 24% 26% 26% 24%
17 20 47 75 98 154 189 110 68
EPS in Rs 21.61 26.01 60.02 19.31 25.00 38.54 47.25 27.52 16.88
Dividend Payout % 13% 10% 9% 5% 6% 4% 4% 5%
Compounded Sales Growth
10 Years: %
5 Years: 12%
3 Years: 12%
TTM: -10%
Compounded Profit Growth
10 Years: %
5 Years: 19%
3 Years: 4%
TTM: -51%
Stock Price CAGR
10 Years: %
5 Years: %
3 Years: -23%
1 Year: 9%
Return on Equity
10 Years: %
5 Years: 27%
3 Years: 25%
Last Year: 14%

Balance Sheet

Standalone Figures in Rs. Crores / View Consolidated

Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Sep 2023
Equity Capital 8 8 8 39 39 40 40 40 40
Reserves 91 108 150 189 282 488 674 776 805
96 84 76 50 43 52 91 93 88
130 120 217 282 261 263 302 250 443
Total Liabilities 325 321 450 560 625 843 1,108 1,159 1,376
37 38 46 51 95 133 193 186 196
CWIP 0 0 1 16 38 10 14 42 55
Investments 0 0 0 0 4 10 2 1 1
287 282 403 493 488 690 898 930 1,125
Total Assets 325 321 450 560 625 843 1,108 1,159 1,376

Cash Flows

Standalone Figures in Rs. Crores / View Consolidated

Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023
52 54 60 98 122
-25 -52 -41 -82 -100
-26 -20 62 -6 -18
Net Cash Flow 1 -18 82 10 4

Ratios

Standalone Figures in Rs. Crores / View Consolidated

Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023
Debtor Days 102 78 100 92 99 102 112 107
Inventory Days 76 86 68 60 83 78 100 122
Days Payable 96 84 129 123 122 92 96 77
Cash Conversion Cycle 83 79 39 29 61 89 116 152
Working Capital Days 98 89 76 58 83 96 116 131
ROCE % 24% 41% 52% 43% 45% 37% 18%

Shareholding Pattern

Numbers in percentages

Mar 2021Jun 2021Sep 2021Dec 2021Mar 2022Jun 2022Sep 2022Dec 2022Mar 2023Jun 2023Sep 2023Dec 2023
74.15% 74.15% 74.61% 74.77% 74.77% 74.83% 74.87% 74.87% 74.90% 74.94% 74.95% 74.95%
3.85% 3.27% 2.64% 2.62% 2.62% 2.27% 2.04% 1.37% 0.00% 0.00% 0.00% 0.00%
4.80% 2.04% 1.58% 1.38% 1.57% 1.68% 1.45% 1.19% 1.21% 0.85% 0.29% 0.23%
17.19% 20.54% 21.17% 21.22% 21.03% 21.22% 21.63% 22.56% 23.89% 24.21% 24.76% 24.82%
No. of Shareholders 1,10,82697,15989,55792,12592,02994,39693,16693,33794,59693,08289,89588,221

* The classifications might have changed from Sep'2022 onwards. The new XBRL format added more details from Sep'22 onwards.

Classifications such as banks and foreign portfolio investors were not available earlier. The sudden changes in FII or DII can be because of these changes.

Click on the line-items to see the names of individual entities.

Documents